Fractionated dosage of radioiodine for the ablation of differentiated thyroid cancer has no impact on survival.

CONCLUSIONS: In the long-term follow-up, radioiodine ablation therapy with fractionated doses in low-risk DTC patients is equally effective as with single dose.
PMID: 29504625 [PubMed - as supplied by publisher]

Source: Endokrynologia Polska - March 5, 2018 Category: Endocrinology Authors: Woliński K, Czepczyński R, Stangierski A, Trojanowski M, Rewaj-Łosyk M, Ziemnicka K, Bączyk M, Dyzmann-Sroka A, Ruchała M Tags: Endokrynol Pol Source Type: research